315 related articles for article (PubMed ID: 20829405)
1. Mechanisms of type I and type II pseudohypoaldosteronism.
Furgeson SB; Linas S
J Am Soc Nephrol; 2010 Nov; 21(11):1842-5. PubMed ID: 20829405
[TBL] [Abstract][Full Text] [Related]
2. Impaired degradation of WNK1 and WNK4 kinases causes PHAII in mutant KLHL3 knock-in mice.
Susa K; Sohara E; Rai T; Zeniya M; Mori Y; Mori T; Chiga M; Nomura N; Nishida H; Takahashi D; Isobe K; Inoue Y; Takeishi K; Takeda N; Sasaki S; Uchida S
Hum Mol Genet; 2014 Oct; 23(19):5052-60. PubMed ID: 24821705
[TBL] [Abstract][Full Text] [Related]
3. WNK4 is indispensable for the pathogenesis of pseudohypoaldosteronism type II caused by mutant KLHL3.
Susa K; Sohara E; Takahashi D; Okado T; Rai T; Uchida S
Biochem Biophys Res Commun; 2017 Sep; 491(3):727-732. PubMed ID: 28743496
[TBL] [Abstract][Full Text] [Related]
4. WNK kinases regulate thiazide-sensitive Na-Cl cotransport.
Yang CL; Angell J; Mitchell R; Ellison DH
J Clin Invest; 2003 Apr; 111(7):1039-45. PubMed ID: 12671053
[TBL] [Abstract][Full Text] [Related]
5. An SGK1 site in WNK4 regulates Na+ channel and K+ channel activity and has implications for aldosterone signaling and K+ homeostasis.
Ring AM; Leng Q; Rinehart J; Wilson FH; Kahle KT; Hebert SC; Lifton RP
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4025-9. PubMed ID: 17360471
[TBL] [Abstract][Full Text] [Related]
6. Role of WNK kinases in regulating tubular salt and potassium transport and in the development of hypertension.
Gamba G
Am J Physiol Renal Physiol; 2005 Feb; 288(2):F245-52. PubMed ID: 15637347
[TBL] [Abstract][Full Text] [Related]
7. ENaC and ROMK activity are inhibited in the DCT2/CNT of TgWnk4
Zhang C; Wang L; Su XT; Zhang J; Lin DH; Wang WH
Am J Physiol Renal Physiol; 2017 Apr; 312(4):F682-F688. PubMed ID: 28365586
[TBL] [Abstract][Full Text] [Related]
8. Kelch-like 3 and Cullin 3 regulate electrolyte homeostasis via ubiquitination and degradation of WNK4.
Shibata S; Zhang J; Puthumana J; Stone KL; Lifton RP
Proc Natl Acad Sci U S A; 2013 May; 110(19):7838-43. PubMed ID: 23576762
[TBL] [Abstract][Full Text] [Related]
9. A molecular update on pseudohypoaldosteronism type II.
Pathare G; Hoenderop JG; Bindels RJ; San-Cristobal P
Am J Physiol Renal Physiol; 2013 Dec; 305(11):F1513-20. PubMed ID: 24107425
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a Wnk4(D561A/+) knockin mouse model.
Yang SS; Morimoto T; Rai T; Chiga M; Sohara E; Ohno M; Uchida K; Lin SH; Moriguchi T; Shibuya H; Kondo Y; Sasaki S; Uchida S
Cell Metab; 2007 May; 5(5):331-44. PubMed ID: 17488636
[TBL] [Abstract][Full Text] [Related]
11. WNK4 regulates the balance between renal NaCl reabsorption and K+ secretion.
Kahle KT; Wilson FH; Leng Q; Lalioti MD; O'Connell AD; Dong K; Rapson AK; MacGregor GG; Giebisch G; Hebert SC; Lifton RP
Nat Genet; 2003 Dec; 35(4):372-6. PubMed ID: 14608358
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Renal Electrolyte Transport by WNK and SPAK-OSR1 Kinases.
Hadchouel J; Ellison DH; Gamba G
Annu Rev Physiol; 2016; 78():367-89. PubMed ID: 26863326
[TBL] [Abstract][Full Text] [Related]
13. WNK-SPAK-NCC cascade revisited: WNK1 stimulates the activity of the Na-Cl cotransporter via SPAK, an effect antagonized by WNK4.
Chávez-Canales M; Zhang C; Soukaseum C; Moreno E; Pacheco-Alvarez D; Vidal-Petiot E; Castañeda-Bueno M; Vázquez N; Rojas-Vega L; Meermeier NP; Rogers S; Jeunemaitre X; Yang CL; Ellison DH; Gamba G; Hadchouel J
Hypertension; 2014 Nov; 64(5):1047-53. PubMed ID: 25113964
[TBL] [Abstract][Full Text] [Related]
14. WNK4 kinase is a physiological intracellular chloride sensor.
Chen JC; Lo YF; Lin YW; Lin SH; Huang CL; Cheng CJ
Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4502-4507. PubMed ID: 30765526
[TBL] [Abstract][Full Text] [Related]
15. A new kindred with pseudohypoaldosteronism type II and a novel mutation (564D>H) in the acidic motif of the WNK4 gene.
Golbang AP; Murthy M; Hamad A; Liu CH; Cope G; Van't Hoff W; Cuthbert A; O'Shaughnessy KM
Hypertension; 2005 Aug; 46(2):295-300. PubMed ID: 15998707
[TBL] [Abstract][Full Text] [Related]
16. WNK1 affects surface expression of the ROMK potassium channel independent of WNK4.
Cope G; Murthy M; Golbang AP; Hamad A; Liu CH; Cuthbert AW; O'Shaughnessy KM
J Am Soc Nephrol; 2006 Jul; 17(7):1867-74. PubMed ID: 16775035
[TBL] [Abstract][Full Text] [Related]
17. Phenotypes of pseudohypoaldosteronism type II caused by the WNK4 D561A missense mutation are dependent on the WNK-OSR1/SPAK kinase cascade.
Chiga M; Rafiqi FH; Alessi DR; Sohara E; Ohta A; Rai T; Sasaki S; Uchida S
J Cell Sci; 2011 May; 124(Pt 9):1391-5. PubMed ID: 21486947
[TBL] [Abstract][Full Text] [Related]
18. WNK kinases: molecular regulators of integrated epithelial ion transport.
Kahle KT; Wilson FH; Lalioti M; Toka H; Qin H; Lifton RP
Curr Opin Nephrol Hypertens; 2004 Sep; 13(5):557-62. PubMed ID: 15300163
[TBL] [Abstract][Full Text] [Related]
19. Decreased ENaC expression compensates the increased NCC activity following inactivation of the kidney-specific isoform of WNK1 and prevents hypertension.
Hadchouel J; Soukaseum C; Büsst C; Zhou XO; Baudrie V; Zürrer T; Cambillau M; Elghozi JL; Lifton RP; Loffing J; Jeunemaitre X
Proc Natl Acad Sci U S A; 2010 Oct; 107(42):18109-14. PubMed ID: 20921400
[TBL] [Abstract][Full Text] [Related]
20. WNK kinases and the control of blood pressure.
Cope G; Golbang A; O'Shaughnessy KM
Pharmacol Ther; 2005 May; 106(2):221-31. PubMed ID: 15866321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
